Molindone Hydrochloride

盐酸吗茚酮

Report date: 2025/02/14 20:00:40
NME

Base Information

Drug NameMolindone Hydrochloride
Drug Alias Name盐酸吗啉吲酮molindona吗啉吲酮MolindonumLidone +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsSchizophreniaConduct DisorderAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsSchizophrenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1974/01/18
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesEndo International Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSupernus Pharmaceuticals IncChartwell Rx Sciences Llc
Active IndicationsN/A
Inactive IndicationsSchizophreniaConduct DisorderAttention Deficit Disorder with Hyperactivity

Other Information

ATC CodeN05AE02
Related LinksWikipediaDrugBankKEGG